Efficacy and safety of empagliflozin in patients with chronic heart failure with reduced ejection fraction combined with impaired glucose tolerance

Hao Zhengyang; Zhang Yanzhou

doi:10.3969/j.issn.1674-4055.2022.09.18

Home>Articles>Efficacy and safety of empagliflozin in patients with chronic heart failure with reduced ejection fraction combined with impaired glucose tolerance

DOI: 10.3969/j.issn.1674-4055.2022.09.18

Efficacy and safety of empagliflozin in patients with chronic heart failure with reduced ejection fraction combined with impaired glucose tolerance

Hao Zhengyang

Zhang Yanzhou

Machine-generated Keywords：

Publication Date：2022-09-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1100-1103 )

Chinese Journal of Evidence-Bases Cardiovascular Medicine

ISTIC

ISSN：1674-4055

Year, Vol.(Issue)：2022,14(9)